Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)

Clinical trial NCT03830333 · COMPLETED

Trial details

NCT number: NCT03830333
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Complicated Intra-abdominal Infections

Start date: 2019-03-20
Primary completion: 2020-10-14
Enrollment: 268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.